AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹24,310 Cr | ₹21,330 Cr | ₹19,653 Cr | ₹17,667 Cr | ₹15,510 Cr |
What is the latest Total Non-Current Assets ratio of AUROBINDO PHARMA ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹24,310 Cr |
| Mar2025 | ₹21,330 Cr |
| Mar2024 | ₹19,653 Cr |
| Mar2023 | ₹17,667 Cr |
| Mar2022 | ₹15,510 Cr |
How is Total Non-Current Assets of AUROBINDO PHARMA Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹24,310 Cr | 13.97 | |
| Mar2025 | ₹21,330 Cr | 8.53 | |
| Mar2024 | ₹19,653 Cr | 11.24 | |
| Mar2023 | ₹17,667 Cr | 13.90 | |
| Mar2022 | ₹15,510 Cr | - | |
Compare Total Non-Current Assets of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹97,818.0 Cr | 0.2% | 4.2% | 53.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 0.2% |
4.2% |
53.1% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses